NEUROGEN CORP
10-Q, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: NEUROGEN CORP, 10-Q, 2000-08-14
Next: YAAK RIVER RESOURCES INC, 10QSB, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>   0000849043
<NAME>  NEUROGEN CORPORATION
<MULTIPLIER>                                   1,000


<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                         102,644
<SECURITIES>                                   13,800
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               118,688
<PP&E>                                         36,632
<DEPRECIATION>                                 11,063
<TOTAL-ASSETS>                                 144,569
<CURRENT-LIABILITIES>                          14,413
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       431
<OTHER-SE>                                     (209)
<TOTAL-LIABILITY-AND-EQUITY>                   144,569
<SALES>                                        0
<TOTAL-REVENUES>                               7,356
<CGS>                                          0
<TOTAL-COSTS>                                  22,680
<OTHER-EXPENSES>                               (2,008)
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                (13,316)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (13,316)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (13,316)
<EPS-BASIC>                                    (0.86)
<EPS-DILUTED>                                  (0.86)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission